Skip to main content

Table 1 Clinicopathological characteristics of clinical samples and expression of ATF5 in 140 bladder cancer

From: Activating transcription factor 5 (ATF5) promotes tumorigenic capability and activates the Wnt/b-catenin pathway in bladder cancer

Characteristics

No. patients

(%)

Age (years)

 ≤ 60

62

(44.3)

 > 60

78

(55.7)

Gender

 Male

106

(75.7)

 Female

34

(24.3)

Grade

 Low grade

103

(73.6)

 High grade

37

(26.4)

Stage

 Ta, T1

110

(78.6)

 T2–T4

30

(21.4)

Tumor size

 ≤ 3 cm

105

(75.0)

 > 3 cm

35

(25.0)

Multiplicity

 1

97

(69.3)

 > 1

43

(30.7)

Expression of ATF5

 High expression

65

(46.4)

 Low expression

75

(53.6)

Recurrence

 Yes

38

(27.1)

 No

102

(72.9)

Progression

 Yes

26

(18.6)

 No

114

(81.4)